Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of the Dual Kinase Inhibitor GW572016 in Combination With Topotecan in Patients With Advanced Solid Malignancies

NCT00295243 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00295243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of the Dual Kinase Inhibitor GW572016 in Combination With Topotecan in Patients With Advanced Solid Malignancies
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2004
Completion date
November 30, 2006
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid malignancies